Analysts at Citizens Jmp began coverage on shares of Slide Insurance (NASDAQ:SLDE - Get Free Report) in a report released on Monday, Marketbeat reports. The brokerage set a "strong-buy" rating and a $25.00 price target on the stock. Citizens Jmp's price target would suggest a potential upside of 34.92% from the stock's current price.
A number of other equities analysts also recently commented on the company. Barclays assumed coverage on Slide Insurance in a report on Monday. They issued an "overweight" rating and a $25.00 price objective on the stock. Morgan Stanley assumed coverage on Slide Insurance in a report on Monday. They issued an "equal weight" rating and a $19.00 price objective on the stock. Wall Street Zen upgraded Slide Insurance to a "hold" rating in a report on Saturday, July 5th. Piper Sandler began coverage on Slide Insurance in a research note on Sunday. They issued an "overweight" rating and a $25.00 target price for the company. Finally, Keefe, Bruyette & Woods upgraded Slide Insurance to a "hold" rating and set a $20.00 target price for the company in a research note on Monday. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $23.17.
Read Our Latest Stock Analysis on SLDE
Slide Insurance Trading Down 4.7%
NASDAQ SLDE opened at $18.53 on Monday. Slide Insurance has a twelve month low of $17.77 and a twelve month high of $25.90.
Insider Buying and Selling
In related news, Director Beth Witte Bruce sold 31,029 shares of the firm's stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $15.81, for a total value of $490,568.49. Following the sale, the director owned 251,645 shares of the company's stock, valued at approximately $3,978,507.45. This trade represents a 10.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Stephen L. Rohde sold 11,082 shares of the firm's stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $15.81, for a total value of $175,206.42. Following the completion of the sale, the director directly owned 9,335 shares in the company, valued at approximately $147,586.35. This trade represents a 54.28% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 427,482 shares of company stock valued at $6,758,490.
Institutional Trading of Slide Insurance
An institutional investor recently bought a new position in Slide Insurance stock. Opal Wealth Advisors LLC bought a new stake in shares of Slide Insurance Holdings, Inc. (NASDAQ:SLDE - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,469 shares of the company's stock, valued at approximately $53,000.
Slide Insurance Company Profile
(
Get Free Report)
Launched in 2021, we are a technology enabled, fast-growing, coastal specialty insurer. We focus on profitable underwriting of single family and condominium policies in the property and casualty (“P&C”) industry in coastal states along the Atlantic seaboard through our insurance subsidiary, Slide Insurance Company (“SIC”).
Read More

Before you consider Slide Insurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Slide Insurance wasn't on the list.
While Slide Insurance currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.